Stroke rate after long-term antiplatelet medication strategy in percutaneous coronary intervention patients using korean national health insurance service (nhis) customized health information database

Back

ESC Premium Access

Stroke rate after long-term antiplatelet medication strategy in percutaneous coronary intervention patients using korean national health insurance service (nhis) customized health information database

Session: Optimising cardiovascular pharmacotherapy

Topic: Drug therapy

Speaker: Associate Professor V. Serebruany (Baltimore, US)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Associate Professor Victor L Serebruany

Johns Hopkins University of Baltimore, Baltimore (United States of America)

2 presentations

0 follower

7 more presentations in this session

Effects of empagliflozin on cardiac and vascular hemodynamic markers by subgroups of age, sex and hypertension in patients with T2DM and high CV risk: EMPA-reg outcome.

Speaker: Doctor O. Johansen (Hovik, NO)

Beneficial effect of beta-blockers on clinical outcomes persist after discontinuation in patients with ST elevation myocardial infarction?

Speaker: Assistant Professor J. Park (Suwon, KR)

Monocyte chemoattractant protein-1 level and (-75)G/A polymorphism of APOA1 gene predict response and resistance to intensive statin therapy in very high cardiovascular risk patients.

Speaker: Professor S. Villevalde (Saint Petersburg, RU)

Efficacy of evinacumab in homozygous familial hypercholesterolemia patients with null or non-null LDL-receptor mutations and on various background therapies

Speaker: Doctor G. Hovingh (Amsterdam, NL)

Access

Abstract

Riociguat ameliorates right ventricular function in patients with pulmonary hypertension.

Speaker: Assistant Professor M. Murata (Kanagawa, JP)

Access the full session

Optimising cardiovascular pharmacotherapy

Speakers: Associate Professor V. Serebruany, Doctor O. Johansen, Assistant Professor J. Park, Professor S. Villevalde, Doctor G. Hovingh...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Stroke rate after long-term antiplatelet medication strategy in percutaneous coronary intervention patients using korean national health insurance service (nhis) customized health information database

About the speaker

Associate Professor Victor L Serebruany

7 more presentations in this session

Effects of empagliflozin on cardiac and vascular hemodynamic markers by subgroups of age, sex and hypertension in patients with T2DM and high CV risk: EMPA-reg outcome.

Beneficial effect of beta-blockers on clinical outcomes persist after discontinuation in patients with ST elevation myocardial infarction?

Monocyte chemoattractant protein-1 level and (-75)G/A polymorphism of APOA1 gene predict response and resistance to intensive statin therapy in very high cardiovascular risk patients.

Efficacy of evinacumab in homozygous familial hypercholesterolemia patients with null or non-null LDL-receptor mutations and on various background therapies

Riociguat ameliorates right ventricular function in patients with pulmonary hypertension.

Access the full session

Optimising cardiovascular pharmacotherapy

About the event

ESC Congress 2017

ESC 365 is supported by